Skip to content

The effect of continuous infusion ?of Meropenem antibiotic ?? in Clinical ?symptoms and Procalcitonin changes in sever sepsis

The effect of continuous infusion ?of Meropenem antibiotic ?? in Clinical ?symptoms and Procalcitonin changes in sever sepsis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141209020258N65
Enrollment
60
Registered
2018-01-31
Start date
2017-05-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute sepsis. Streptococcal sepsis, unspecified

Interventions

Intervention 1: Intervention group: En Immediately after the initial diagnosis patients in the intervention group (30), one gram of ?morophenem in one bolus and 100 milligram in hours of antibiotic ma
Treatment - Drugs
Intervention group: En Immediately after the initial diagnosis patients in the intervention group (30), one gram of ?morophenem in one bolus and 100 milligram in hours of antibiotic maroponum, receive
Control group: Patients in the control group (n = 30) received one gram of moropenum as bolus dosing ?every 12 hours and 10 cc per hour of normal saline for continuous infusion over a period ?of 72 .

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 18-75 years Patients admitted to ICU with the diagnosis of evidence of infection and at least two of the symptoms of SIRS (sepsis)

Exclusion criteria

Exclusion criteria: Incidence of drug-related complications No response to treatment within 72 hours

Design outcomes

Primary

MeasureTime frame
Changes in Procalcitonin. Timepoint: Before and 2 weeks after treatment. Method of measurement: milligram.;GFR. Timepoint: Before and 2 weeks after treatment. Method of measurement: count.;Level of consciousness. Timepoint: At the time of arrival, 24, 48 and 72 hours after receiving the drug. Method of measurement: Glasgow scale.;Incidence of mortality. Timepoint: Before and 2 weeks after treatment. Method of measurement: Number.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026